Home
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Actos Articles
Popular Actos Articles
Highly Recommended Actos Articles
Email to a Friend
Send a link to this page to your friends and colleagues.
ACTOplus Met Approved by the FDA for Type 2 Diabetes
New product combines two widely used diabetes medications in a single tablet
In August 2005, Takeda Pharmaceuticals North America, Inc., announced that the U.S. Food and Drug Administration (FDA) had approved ACTOplus Met for the treatment of type 2 diabetes.
The new medication combines the two popular type 2 drugs Actos (pioglitazone HCl) and metformin HCl, providing convenience to patients.
ACTOplus met will be available in two dosages of pioglitazone with metformin: 15 mg/500 mg and 15 mg/850 mg. The medication is taken once a day or in divided doses.
Side Effects
According to Takeda, a small number of people who have taken metformin, a component of ACTOplus met, have developed a rare but serious condition called lactic acidosis—a buildup of lactic acid in the blood, which can be fatal in about half of cases. ACTOplus met should not be used in people with kidney disease or in people 80 years of age and older who have any problems with kidney function.
Actos and ACTOplus met can cause fluid retention (swelling) that may lead to or worsen heart failure. Talk to your doctor immediately if you experience rapid weight gain, fluid retention or shortness of breath while taking either drug.
Your health professional should perform a blood test to check for liver problems before you start Actos or ACTOplus met and periodically thereafter. Do not take Actos or ACTOplus met if you have active liver disease.
You should also talk to your doctor immediately if you experience nausea, vomiting, stomach pain, tiredness, loss of appetite, dark urine or yellowing of the skin.
For more information, log on to www.actos.com.
* * *
Source: Takeda Pharmaceuticals
Categories: Actos, Diabetes, Diabetes, Food, Government & Policy, Medications, Metformin, Type 2 Issues, Type 2 Medications
You May Also Be Interested In...
-
Diabetes Health
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
-
Topics
- Diabetic / Diabetes Health
- Type 1 / 1.5 Diabetes
- Type 2 Diabetes
- Blood Glucose / Sugar
- High/Low Blood Sugar / Fast Acting Glucose
- Insulin- Pumps, Pens & Syringes
- Continuous Glucose Monitors, CGM, Infusion Sets
- Type 2 Medications
- Hyperglycemia
- Hypoglycemia
Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...